Stock Information

Information relating to Kiadis Pharma’s share price, shareholders and covering analysts can be found in this section.

Substantial Shareholdings

Institutional investors hold approximately 75% of the voting rights in Kiadis Pharma N.V., with the remaining shares held by retail investors, broker-dealers and others.

Please consult the website of the Netherlands Authority for Financial Markets (AFM) for details of investors who have disclosed shareholdings in Kiadis Pharma N.V. to the AFM.

Analyst Coverage

The following research institutions cover Kiadis Pharma N.V.



Peter Welford

KBC Securities


Lenny Van Steenhuyse

Kempen & Co


Anastasia Karpova

Canaccord Genuity Inc.


John Newman



Keay Nakae



Mark Breidenbach



Anita Ye

Piper Jaffrey


Edward A. Tenthoff